ZNF625
gene geneOn this page
Summary
ZNF625 (zinc finger protein 625, HGNC:30571) is a protein-coding gene on chromosome 19p13.2, encoding Zinc finger protein 625 (Q96I27). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 90589 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 36 total
- MANE Select transcript:
NM_145233
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30571 |
| Approved symbol | ZNF625 |
| Name | zinc finger protein 625 |
| Location | 19p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000257591 |
| Ensembl biotype | protein_coding |
| Entrez | 90589 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000414892, ENST00000439556, ENST00000455799
RefSeq mRNA: 1 — MANE Select: NM_145233
NM_145233
CCDS: CCDS12269
Canonical transcript exons
ENST00000439556 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001628058 | 12144890 | 12146224 |
| ENSE00002353231 | 12156556 | 12156734 |
| ENSE00003467303 | 12147676 | 12147802 |
| ENSE00003622438 | 12147395 | 12147455 |
Expression profiles
Bgee: expression breadth ubiquitous, 160 present calls, max score 86.07.
FANTOM5 (CAGE): breadth broad, TPM avg 0.6641 / max 22.7727, expressed in 358 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 179291 | 5.4830 | 1413 |
| 179290 | 0.4125 | 214 |
| 179292 | 0.2516 | 115 |
Top tissues by expression
243 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ventricular zone | UBERON:0003053 | 86.07 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.80 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.00 | gold quality |
| ganglionic eminence | UBERON:0004023 | 81.63 | gold quality |
| cortical plate | UBERON:0005343 | 77.23 | gold quality |
| calcaneal tendon | UBERON:0003701 | 75.06 | gold quality |
| adrenal tissue | UBERON:0018303 | 73.55 | gold quality |
| stromal cell of endometrium | CL:0002255 | 72.83 | gold quality |
| metanephros cortex | UBERON:0010533 | 70.22 | gold quality |
| granulocyte | CL:0000094 | 69.78 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 69.70 | gold quality |
| islet of Langerhans | UBERON:0000006 | 69.68 | gold quality |
| cerebellar cortex | UBERON:0002129 | 69.56 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 69.49 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 69.42 | gold quality |
| sural nerve | UBERON:0015488 | 69.38 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 68.87 | gold quality |
| left adrenal gland | UBERON:0001234 | 68.71 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 68.58 | gold quality |
| adenohypophysis | UBERON:0002196 | 68.51 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 68.38 | gold quality |
| right adrenal gland | UBERON:0001233 | 68.18 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 68.14 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 68.11 | gold quality |
| tendon | UBERON:0000043 | 68.08 | gold quality |
| hypothalamus | UBERON:0001898 | 68.02 | gold quality |
| cerebellum | UBERON:0002037 | 67.95 | gold quality |
| thyroid gland | UBERON:0002046 | 67.78 | gold quality |
| adrenal gland | UBERON:0002369 | 67.62 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 67.51 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.64 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
13 targeting ZNF625, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-2681-5P | 99.75 | 67.64 | 1655 |
| HSA-MIR-6815-3P | 99.13 | 68.98 | 1530 |
| HSA-MIR-939-3P | 98.97 | 65.07 | 2347 |
| HSA-MIR-6895-3P | 98.79 | 65.69 | 996 |
| HSA-MIR-606 | 98.72 | 67.34 | 960 |
| HSA-MIR-619-5P | 98.57 | 64.97 | 1988 |
| HSA-MIR-4799-3P | 97.78 | 65.97 | 893 |
| HSA-MIR-4720-5P | 97.46 | 65.67 | 893 |
| HSA-MIR-5588-5P | 97.46 | 65.70 | 913 |
| HSA-MIR-134-5P | 97.11 | 66.52 | 976 |
| HSA-MIR-3118 | 97.11 | 66.58 | 984 |
| HSA-MIR-450A-5P | 93.89 | 64.57 | 50 |
Cross-species orthologs
0 orthologs
Paralogs (51): WIZ (ENSG00000011451), ZNF416 (ENSG00000083817), MYNN (ENSG00000085274), PRDM4 (ENSG00000110851), PRDM2 (ENSG00000116731), ZBTB17 (ENSG00000116809), ZNF644 (ENSG00000122482), GZF1 (ENSG00000125812), ZNF426 (ENSG00000130818), ZNF287 (ENSG00000141040), ZNF697 (ENSG00000143067), ZNF687 (ENSG00000143373), ZNF214 (ENSG00000149050), ZNF547 (ENSG00000152433), ZNF776 (ENSG00000152443), ZNF230 (ENSG00000159882), ZNF222 (ENSG00000159885), ZNF233 (ENSG00000159915), ZNF333 (ENSG00000160961), ZNF319 (ENSG00000166188), ZNF592 (ENSG00000166716), ZNF646 (ENSG00000167395), ZNF507 (ENSG00000168813), ZNF768 (ENSG00000169957), ZNF417 (ENSG00000173480), ZNF408 (ENSG00000175213), ZBTB41 (ENSG00000177888), ZNF223 (ENSG00000178386), ZNF852 (ENSG00000178917), ZNF784 (ENSG00000179922), ZNF572 (ENSG00000180938), ZNF707 (ENSG00000181135), ZNF746 (ENSG00000181220), ZNF467 (ENSG00000181444), ZNF530 (ENSG00000183647), ZNF17 (ENSG00000186272), ZNF527 (ENSG00000189164), ZKSCAN7 (ENSG00000196345), ZNF34 (ENSG00000196378), ZNF774 (ENSG00000196391)
Protein
Protein identifiers
Zinc finger protein 625 — Q96I27 (reviewed: Q96I27)
All UniProt accessions (3): Q96I27, F2Z3I2, H7C2C9
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96I27-1 | 1 | yes |
| Q96I27-2 | 2 |
RefSeq proteins (1): NP_660276* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF13912
UniProt features (14 total): zinc finger region 9, chain 1, region of interest 1, modified residue 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96I27-F1 | 76.26 | 0.52 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 209
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 18 (showing top):
GOZGIT_ESR1_TARGETS_DN, chr19p13, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ZNF350_TARGET_GENES, ZNF513_TARGET_GENES, GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_DN, MIR6895_3P, SMN1_SMN2_TARGET_GENES, SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_UP, GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_UP, GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_UP, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY, GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_DN, GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_DN
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
306 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF625 | A0A087WYV9 | A0A087WYV9 | 507 |
| ZNF625 | A0A0A6YYL1 | A0A0A6YYL1 | 447 |
| ZNF625 | BEND5 | Q7L4P6 | 397 |
| ZNF625 | MDFI | Q99750 | 348 |
| ZNF625 | CCDC180 | Q9P1Z9 | 348 |
| ZNF625 | DMRTC2 | Q8IXT2 | 347 |
| ZNF625 | ZGLP1 | P0C6A0 | 334 |
| ZNF625 | AMER2 | Q8N7J2 | 323 |
| ZNF625 | TMEM240 | Q5SV17 | 322 |
| ZNF625 | LRRC31 | Q6UY01 | 317 |
| ZNF625 | TAF6L | Q9Y6J9 | 306 |
| ZNF625 | GNA15 | P30679 | 303 |
| ZNF625 | RUNDC3B | Q96NL0 | 293 |
| ZNF625 | MIER3 | Q7Z3K6 | 278 |
| ZNF625 | ZNF385B | Q569K4 | 274 |
IntAct
19 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF625 | KRTAP10-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-7 | ZNF625 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-9 | ZNF625 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF625 | KRT40 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF625 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| KRTAP10-4 | ZNF625 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF625 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| ZNF625 | KRTAP10-9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ECE1 | ZNF625 | psi-mi:“MI:0915”(physical association) | 0.370 |
| CBX5 | ZNF568 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF625 | GGPS1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (14): KRT40 (Two-hybrid), KRTAP10-4 (Two-hybrid), KRTAP10-7 (Two-hybrid), KRTAP10-9 (Two-hybrid), KRTAP10-3 (Two-hybrid), ZNF625 (Reconstituted Complex), ZNF625 (Two-hybrid), ZNF625 (Two-hybrid), ZNF625 (Proximity Label-MS), RRBP1 (Proximity Label-MS), KPRP (Affinity Capture-MS), GGPS1 (Affinity Capture-MS), ZNF625 (Affinity Capture-MS), ZNF625 (Affinity Capture-MS)
ESM2 similar proteins: A0A1W2PQL4, A6NK53, A8MUZ8, A8MWA4, B1APH4, E7ETH6, O14628, O60384, P0CH99, P0CI00, P17024, P21506, P51502, P52741, P52743, P52744, Q0D2J5, Q13360, Q14593, Q15940, Q15973, Q4R882, Q5FWF6, Q5HY98, Q5JVG8, Q5RES8, Q6NX49, Q6P280, Q6V9R5, Q6ZN79, Q7L945, Q8BZW4, Q8IVC4, Q8IW36, Q8IZC7, Q8N587, Q8NDP4, Q8NE65, Q96H40, Q96I27
Diamond homologs: A0JPK3, A2RRD8, A2VDQ7, A3KN32, A8MUZ8, A8MWA4, C9JN71, E9QAG8, O60384, O60765, O75820, P0CH99, P0CI00, P10076, P10755, P15621, P16374, P16415, P17017, P17024, P51523, P52737, P52740, Q06730, Q06732, Q08AG5, Q0D2J5, Q13106, Q13360, Q15928, Q15935, Q15973, Q32M78, Q3KP31, Q4R4C7, Q4R6J4, Q4R882, Q5R9F0, Q5RC79, Q5REI6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
36 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 36 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
862 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:12146223:CT:C | acceptor_gain | 1.0000 |
| 19:12146225:C:CC | acceptor_gain | 1.0000 |
| 19:12147671:CTTA:C | donor_loss | 1.0000 |
| 19:12147672:TTA:T | donor_loss | 1.0000 |
| 19:12147673:TACCT:T | donor_loss | 1.0000 |
| 19:12147674:A:AC | donor_gain | 1.0000 |
| 19:12147675:C:CC | donor_gain | 1.0000 |
| 19:12147675:C:CT | donor_loss | 1.0000 |
| 19:12147675:CCTA:C | donor_gain | 1.0000 |
| 19:12147801:TC:T | acceptor_gain | 1.0000 |
| 19:12147802:CC:C | acceptor_gain | 1.0000 |
| 19:12147813:CCACA:C | acceptor_gain | 1.0000 |
| 19:12147814:C:CT | acceptor_gain | 1.0000 |
| 19:12147814:C:T | acceptor_gain | 1.0000 |
| 19:12147814:CACA:C | acceptor_gain | 1.0000 |
| 19:12147816:CA:C | acceptor_gain | 1.0000 |
| 19:12147817:A:C | acceptor_gain | 1.0000 |
| 19:12147819:G:C | acceptor_gain | 1.0000 |
| 19:12156553:CAC:C | donor_loss | 1.0000 |
| 19:12156554:A:AC | donor_gain | 1.0000 |
| 19:12156554:AC:A | donor_gain | 1.0000 |
| 19:12156554:ACCA:A | donor_loss | 1.0000 |
| 19:12156554:ACCAT:A | donor_loss | 1.0000 |
| 19:12156555:C:A | donor_loss | 1.0000 |
| 19:12156555:C:CC | donor_gain | 1.0000 |
| 19:12156555:CC:C | donor_gain | 1.0000 |
| 19:12156555:CCA:C | donor_gain | 1.0000 |
| 19:12146220:GACCT:G | acceptor_gain | 0.9900 |
| 19:12146221:ACCTC:A | acceptor_loss | 0.9900 |
| 19:12146224:TCTGT:T | acceptor_loss | 0.9900 |
AlphaMissense
2472 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000235145 (19:12155969 GC>G,GCC), RS1000247500 (19:12150132 A>G,T), RS1000319240 (19:12149762 G>A), RS1000548840 (19:12147508 G>A), RS1000700716 (19:12154454 G>A), RS1000757280 (19:12154087 G>A), RS1000837389 (19:12154212 C>T), RS1001211295 (19:12150902 G>A), RS1001263635 (19:12150550 C>T), RS1001591273 (19:12149228 T>C), RS1001737016 (19:12155160 A>C), RS1001772156 (19:12157294 C>T), RS1002213567 (19:12149239 C>G,T), RS1002267696 (19:12148873 C>G,T), RS1002367101 (19:12156067 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| butyraldehyde | increases expression | 1 |
| cupric oxide | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| bisphenol S | increases methylation | 1 |
| Leflunomide | increases expression | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation, decreases methylation | 1 |
| Folic Acid | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | increases expression | 1 |
| Acrylamide | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.